A systematic review and meta‐analysis of gene therapy in animal models of cerebral glioma: why did promise not translate to human therapy?
Evidence-based Preclinical Medicine · 2014
DOI: 10.1002/ebm2.6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Evidence-based Preclinical Medicine, 2014. Verfasst von T C Hirst und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Clinical Brain Sciences Chancellors Building University of Edinburgh Edinburgh UK. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Centre for the Replacement, Refinement and Reduction of Animals in Research.
Abstract (Originalsprache)
Background
The development of therapeutics is often characterized by promising animal research that fails to translate into clinical efficacy; this holds for the development of gene therapy in glioma. We tested the hypothesis that this is because of limitations in the internal and external validity of studies reporting the use of gene therapy in experimental glioma.
Method
We systematically identified studies testing gene therapy in rodent glioma models by searching three online databases. The number of animals treated and median survival were extracted and studies graded using a quality checklist. We calculated median survival ratios and used random effects meta‐analysis to estimate efficacy. We explored effects of study design and quality and searched for evidence of publication bias.
Results
We identified 193 publications using gene therapy in experimental glioma, including 6,366 animals. Overall, gene therapy improved median survival by a factor of 1.60 (95% CI 1.53–1.67). Study quality was low and the type of gene therapy did not account for differences in outcome. Study design characteristics accounted for a significant proportion of between‐study heterogeneity. We observed similar findings in a data subset limited to the most common gene therapy.
Conclusion
As the dysregulation of key molecular pathways is characteristic of gliomas, gene therapy remains a promising treatment for glioma. Nevertheless, we have identified areas for improvement in conduct and reporting of studies, and we provide a basis for sample size calculations. Further work should focus on genes of interest in paradigms recapitulating human disease. This might improve the translation of such therapies into the clinic.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Clinical Brain Sciences Chancellors Building University of Edinburgh Edinburgh UK.
- Florey Neuroscience and Mental Health Institute University of Melbourne Victoria Australia.
- Division of Clinical Neurosciences University of Edinburgh Western General Hospital Edinburgh UK.
- Centre for Clinical Brain Sciences Chancellors Building University of Edinburgh Edinburgh UK; Florey Neuroscience and Mental Health Institute University of Melbourne Victoria Australia.
Förderung
- National Centre for the Replacement, Refinement and Reduction of Animals in Research
Zitieren
APA
Hirst, T. C., Vesterinen, H. M., Conlin, S., Egan, K. J., Antonic, A., Lawson McLean, A., Macleod, M. R., Grant, R., Brennan, P. M., Sena, E. S., & Whittle, I. R. (2014). A systematic review and meta‐analysis of gene therapy in animal models of cerebral glioma: why did promise not translate to human therapy?. Evidence-based Preclinical Medicine. https://doi.org/10.1002/ebm2.6
Vancouver
Hirst TC, Vesterinen HM, Conlin S, Egan KJ, Antonic A, Lawson McLean A, et al. A systematic review and meta‐analysis of gene therapy in animal models of cerebral glioma: why did promise not translate to human therapy?. Evidence-based Preclinical Medicine. 2014. doi:10.1002/ebm2.6
BibTeX
@article{Hirst2014,
author = {Hirst, T C and Vesterinen, H M and Conlin, S and Egan, K J and Antonic, A and Lawson McLean, A and Macleod, M R and Grant, R and Brennan, P M and Sena, E S and Whittle, I R},
title = {A systematic review and meta‐analysis of gene therapy in animal models of cerebral glioma: why did promise not translate to human therapy?},
journal = {Evidence-based Preclinical Medicine},
year = {2014},
doi = {10.1002/ebm2.6}
}
EUVIMED